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Abstract: Modelling cell infection in-a-dish can represent a useful tool to understand the
susceptibility of different cell types towards severe acute respiratory coronavirus-2
(SARS-CoV-2) and to decipher its neurotropism. In this perspective, retinoic acid (RA)-
differentiated neuroblastoma cell lines, SH-SY5Y and SK-N-BE(2) and glioblastoma
cell lines, U-87 MG and U-373 MG, were infected with a SARS-CoV-2 strain, at various
multiplicity-of-infection (MOI). We first demonstrated that the common entry genes -
needed for invading epithelial cells - were expressed. RA-differentiation induced an
upregulation of  ace2  and  tmprss2  gene expression while inducing downregulation of
ctsb  and  ctsl  . Using  in situ  hybridization and confocal analysis, SARS-CoV-2  gene
S  RNA was detected intracellularly at MOI 5.0, and localized in both soma and
neuritic-like or glial-like processes. The infection was confirmed by quantification of
viral  gene E  RNA and showed a dose-dependency, with few infected cells at MOI 0.1.
After 24 hours of infection, no cytopathic effect was observed in SH-SY5Y abilities to
maintain neuritic processes or in U-373 MG for the uptake of glutamate. Unlike the
permissive Vero E6 cells, no significant apoptosis death was detected following SARS-
CoV-2 infection of neuroblastoma or glioblastoma cells.   This study demonstrates the
susceptibility of neuronal- and glial-like cell lines towards SARS-CoV-2 infection at high
MOIs. Once inside the cells, the virus does not seem to rapidly replicate nor exert
major cytopathic effect. Overall, our results strengthen the idea that SARS-CoV-2 has
a tropism for nervous cells that express commonly described entry genes.
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Dear Dr. Matthew J. LaVoie, 
 
Enclosed for review at Brain Research is the manuscript entitled “Susceptibility of neuroblastoma and 
glioblastoma cell lines to SARS-CoV-2 infection”. We believe that it will perfectly fit the scope of the 
section “Neurobiology of Disease”. 
 
In the context of the COVID-19 pandemic, we deciphered the susceptibility and permissiveness of 
neuroblastoma and glioblastoma cell lines towards SARS-CoV-2 infection. Knowing that the 
neurotropism of SARS-CoV-2 is more and more established, modelling cell infection in-a-dish can 
represent a useful tool to understand the CNS entry mechanisms and to develop therapeutic 
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neuroblastoma and glioblastoma cell lines, without exerting major cytopathic effect on either neuron-
like morphology or on functional glutamate uptake. More interestingly, in all infected cells, the 
intracellular distribution included both the soma compartment and the neuritic-like or glial-like 
processes.  
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CoV-2 neurotropism. 
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Dear Dr. Matthew J. LaVoie, 
Dear Dr. Cesar V. Borlongan, 
 
Enclosed for publication at Brain Research is the revision of the manuscript entitled “Susceptibility of 
neuroblastoma and glioblastoma cell lines to SARS-CoV-2 infection”.  
 
We have addressed all of the comments of both reviewers. We have enclosed along with the manuscript 
a point-by-point set of responses to each reviewer comment, and we have made all of the necessary 
changes to the manuscript text. We appreciate the helpful comments of both reviewers, and we feel 
that the changes made based on their input have made for an improved manuscript. 
 
I hope that you will be able to send this resubmission back to the original reviewers. If so, I look 
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Université de Namur 
Faculté de Médecine, URPhyM - NARILIS 










Université de Namur, ASBL 




Reviewer #1: In the present investigation, Bielarz and colleagues analyzed the neurotropism of 
SARS-COV-2. They used differentiated neuroblastoma cell lines and glioblastoma cell lines, at 
various multiplicity-of-infection (MOI). This study demonstrates the susceptibility of neuronal- 
and glial-like cell lines towards SARS-CoV-2 infection at high MOIs. Once inside the cells, the 
virus does not seem to rapidly replicate nor exert major cytopathic effect. Overall, these results 
confirmed that SARS-COV-2 has a strong neurotropism for nervous cells expressing ace2 and 
tmprss2. This investigation is of high interest for the scientific community and the 
experimental design as well the methods are adequate. However, this reviewer has some points 
to raise: 
1) The Authors should strengthen the Introduction section, reporting more references 
regarding SARS-COV-2 and the neurotropism. 
Besides 16 references already listed in the introduction, we have included 5 most recent published 
findings about neuroinvasion abilities (Patterson et al.; Meinhardt et al.; Kumari et al.; Song et al.; 
Cantuti-Castelvetri et al.). Many other pending manuscripts can be found as preprints on free 
platforms (such as bioRxiv, medRxiv) and, from my point-of-view, I do not feel comfortable to refer 
those yet unpublished or (maybe) non-peer reviewed papers. 
 
2) Since the Authors analyzed also tmprss2, they should at least mention it in the 
introduction. 
We have now added few sentences mentioning TMPRSS2 role in SARS-CoV-2 fusion activation as 
well as the distribution of entry proteins along the respiratory tract (page 5, line 24). 
 
3) The Authors should add the scale bar in Figure 1c. 
We inserted a scale bar in Figure 2c (renumbered according to ref#2 suggestion). 
 
 
Reviewer #2: The present study examined the susceptibility of neuroblastoma and glioblastoma 
cell lines to SARS-CoV-2 infection. These are interesting data. However, there are a few 
oversights that require the authors' attention. 
1. In methods part, the authors need to briefly discuss the effect of cell culture media for U87 
and U373 cell line. 
Both cell lines are usually cultured in minimum essential growth medium (MEM) supplemented with 
10% FBS. Lowering the serum concentration to 2% or to no-serum condition will definitely impact 
the cell behavior such as proliferation, adhesion, migration, secretome or abilities to form 
neurospheres (Motaln et al., Oncotarget, 2015). As we did not use serum-free medium in our 
experimental paradigm, we did not expect to induce major starvation stress. Although we did not 
assay it, we definitely observed a slower growth rate upon switching medium from 10% to 2%. We 
do not feel that the effect of medium or serum is worth discussing in the context of glioblastoma 
infection by SARS-CoV-2. 
 
2. In cell culture media for SH-Sy5Y and SK-N-BE(2), why did the authors use low-serum 
medium? 
While basal growth medium contains 10% FBS, the content of FBS is usually lowered to 2% FBS in 
the medium used for viral infection. This is a standard procedure, even that in some cases, the 
medium after infection is switched to a serum-free medium. We did not find any rational explanation 
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plasminogen, complement factors …) interfere with viral adsorption by cleaving surface cell/virus 
entry receptors or inhibiting their interactions. According to ATCC recommendations, a low-serum 
condition is a standard procedure upon viral infection of cells in culture 
(https://www.atcc.org/~/media/PDFs/webinars/Presentations/2017/Culturing%20Viruses%20Webina
r_10-2017.ashx). With respect to in vitro SARS-CoV-2 infection of nervous cells, only one 
publication mentioned the use of a serum-free medium during infection (Bullen et al., ALTEX, 
2020), the others lacked this type of information.  
 
3. The authors used RNAscope kit. Authors need to mention the RNAscope procedure in the 
methods section. 
The procedure was already mentioned in the material and methods (see section 4.4.). 
 
4. For figure 1, (a) the authors need to show counterstaining with nuclear marker, like 
Hoechst. (c) Also, the authors need to add scale bars in pictures. 
Fluorescent ish pictures labeled with nCoV2019 probe are now counterstained with Hoechst in 
Figure 2a (renumbered according to ref’s suggestion). 
 
5. The authors need to rearrange the order of the figures with supplemental figures to match 
with the order as presented in the results section (ex fig1 -4). 
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Modelling cell infection in-a-dish can represent a useful tool to understand the susceptibility of 1 
different cell types towards severe acute respiratory coronavirus-2 (SARS-CoV-2) and to 2 
decipher its neurotropism. In this perspective, retinoic acid (RA)-differentiated neuroblastoma 3 
cell lines, SH-SY5Y and SK-N-BE(2) and glioblastoma cell lines, U-87 MG and U-373 MG, 4 
were infected with a SARS-CoV-2 strain, at various multiplicity-of-infection (MOI). We first 5 
demonstrated that the common entry genes - needed for invading epithelial cells - were 6 
expressed. RA-differentiation induced an upregulation of ace2 and tmprss2 gene expression 7 
while inducing downregulation of ctsb and ctsl. Using in situ hybridization and confocal 8 
analysis, SARS-CoV-2 gene S RNA was detected intracellularly at MOI 5.0, and localized in 9 
both soma and neuritic-like or glial-like processes. The infection was confirmed by 10 
quantification of viral gene E RNA and showed a dose-dependency, with few infected cells at 11 
MOI 0.1. After 24 hours of infection, no cytopathic effect was observed in SH-SY5Y abilities 12 
to maintain neuritic processes or in U-373 MG for the uptake of glutamate. Unlike the 13 
permissive Vero E6 cells, no significant apoptosis death was detected following SARS-CoV-2 14 
infection of neuroblastoma or glioblastoma cells.  This study demonstrates the susceptibility of 15 
neuronal- and glial-like cell lines towards SARS-CoV-2 infection at high MOIs. Once inside 16 
the cells, the virus does not seem to rapidly replicate nor exert major cytopathic effect. Overall, 17 
our results strengthen the idea that SARS-CoV-2 has a tropism for nervous cells that express 18 
commonly described entry genes.   19 
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Abstract (< 250 words) 1 
Modelling cell infection in-a-dish can represent a useful tool to understand the susceptibility of 2 
different cell types towards severe acute respiratory coronavirus-2 (SARS-CoV-2) and to 3 
decipher its neurotropism. In this perspective, retinoic acid (RA)-differentiated neuroblastoma 4 
cell lines, SH-SY5Y and SK-N-BE(2) and glioblastoma cell lines, U-87 MG and U-373 MG, 5 
were infected with a SARS-CoV-2 strain, at various multiplicity-of-infection (MOI). We first 6 
demonstrated that the common entry genes - needed for invading epithelial cells - were 7 
expressed. RA-differentiation induced an upregulation of ace2 and tmprss2 gene expression 8 
while inducing downregulation of ctsb and ctsl. Using in situ hybridization and confocal 9 
analysis, SARS-CoV-2 gene S RNA was detected intracellularly at MOI 5.0, and localized in 10 
both soma and neuritic-like or glial-like processes. The infection was confirmed by 11 
quantification of viral gene E RNA and showed a dose-dependency, with few infected cells at 12 
MOI 0.1. After 24 hours of infection, no cytopathic effect was observed in SH-SY5Y abilities 13 
to maintain neuritic processes or in U-373 MG for the uptake of glutamate. Unlike the 14 
permissive Vero E6 cells, no significant apoptosis death was detected following SARS-CoV-2 15 
infection of neuroblastoma or glioblastoma cells.  This study demonstrates the susceptibility of 16 
neuronal- and glial-like cell lines towards SARS-CoV-2 infection at high MOIs. Once inside 17 
the cells, the virus does not seem to rapidly replicate nor exert major cytopathic effect. Overall, 18 
our results strengthen the idea that SARS-CoV-2 has a tropism for nervous cells that express 19 
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1. Introduction 1 
Most of the time, the infection with severe acute respiratory syndrome coronavirus 2 (SARS-2 
CoV-2) causes respiratory symptoms, known as coronavirus disease 2019 (COVID-19), 3 
although a minority of patients are at risk of developing a severe form with extrapulmonary 4 
involvements (for review (Gupta et al., 2020)). Severely SARS-CoV-2-affected patients are 5 
more likely to develop neurologic symptoms (e.g. headache, epilepsy, confusion, nausea and 6 
vomiting) than patients with a mild form of COVID-19 (Asadi-Pooya and Simani, 2020; Mao 7 
et al., 2020a; Paterson et al., 2020). Among the worst neurologic cases, viral encephalitis, 8 
necrotizing encephalopathy, acute myelitis or Guillain-Barré syndrome were reported (Chen et 9 
al., 2020; Kilinc et al., 2020; Mao et al., 2020a; Moriguchi et al., 2020; Poyiadji et al., 2020; 10 
Zhao et al., 2020). Intriguingly, some patients developed neurologic symptoms even prior to 11 
any respiratory manifestation. In one retrospective study, up to 88% among the severe patients 12 
showed acute cerebrovascular diseases associated with impaired consciousness (Mao et al., 13 
2020b). Neuro-imaging supports substantial brain damages in both COVID-19 survivors and 14 
non-survivors (Coolen et al., 2020; Helms et al., 2020; Zanin et al., 2020). Increasing evidences 15 
show the presence of SARS-Cov-2 in brain post-mortem tissue (Bulfamante et al., 2020; Paniz-16 
Mondolfi et al., 2020; Puelles et al., 2020; Song et al., 2021), even though the mechanisms and 17 
routes of CNS entry are still elusive. 18 
SARS-CoV-2 belongs to the same beta‐coronaviruses family as SARS-CoV (2003 China 19 
outbreak) and shares up to 79,6% pairwise identities on a genomic level with its cousin (Lu et 20 
al., 2020). SARS-CoV-2 also shares common entry mechanisms used to invade target cells, 21 
including the binding of the spike (S) protein to human ACE2 receptor. S protein sequence was 22 
found to be approximately 77% homologous between SARS-CoV-2 and SARS-CoV. SARS-23 
CoV-2 entry also depends on TMPRSS2 protease activity, which helps at ACE2 cleavage and 24 
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al., 2020). Alternatively, cathepsin B or L may be able to substitute for TMPRSS2 in early 1 
endosomes upon endocytosis. ACE2 and TMPRSS2 have been detected at high expression 2 
levels in nasal, bronchial epithelium, as well as in alveolar epithelium (mostly type II 3 
pneumocytes), which explains the central respiratory pathology (Ortiz et al., 2020). Previously, 4 
neuro-invasion abilities of SARS-CoV have been firmly demonstrated on both patients and 5 
experimental animal models (Gu et al., 2005; Netland et al., 2008). Evidence from transgenic 6 
humanized ACE2 mice showed that SARS-CoV is able to enter the nervous system through the 7 
neuro-olfactory epithelium. It is then carried along the olfactory nerve up to the olfactory bulb, 8 
where it starts to spread to neighboring nervous cells (Netland et al., 2008). Similar SARS-9 
CoV-2 neurotropic properties and CNS entry routes are under investigation. Of note, infected 10 
cells from the olfactory neuro-epithelium are suggested as gateways to central nervous system 11 
invasion in some individuals with COVID-19 (Cantuti-Castelvetri et al., 2020; Meinhardt et al., 12 
2020). Such an entry route was demonstrated as plausible in transgenic humanized ACE2 mice 13 
following experimental intranasal instillation of SARS-CoV-2 (Kumari et al., 2021).  14 
So far,  in vitro data showed the permissiveness of U-251 glioblastoma cell line to SARS-CoV-15 
2 infection (Chu et al., 2020). Recently, evidences from four five independent groups converge 16 
to show that human neural progenitor cells, grown either as neurospheres or as brain organoids, 17 
are susceptible to SARS-CoV-2 infection (Bullen et al., 2020; Ramani et al., 2020; Song et al., 18 
2021; Yang et al., 2020; Zhang et al., 2020). In the present report, we aim at investigating the 19 
susceptibility of neuroblastoma and glioblastoma cell lines towards SARS-CoV-2 infection. 20 
These respective neuron-like and glial-like cells might represent useful tools to decipher the 21 
entry, replication and cytopathic effect of SARS-CoV-2 in the CNS. 22 
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2. Results 1 
Before infecting the various neural cell lines with a Belgian SARS-CoV-2 strain, we sought to 2 
explore their expression level of entry genes, encoding proteins commonly needed by SARS-3 
CoV-2 for invading human host cells. The transcripts for ace2 and tmprss2 genes were detected 4 
in both neuroblastoma (SH-SY5Y and SK-N-BE(2)) and both glioblastoma (U-87 MG and U-5 
373 MG) cells, however in lower amounts than those of hprt housekeeping gene (Suppl. Fig. 6 
ure 1a). Interestingly, RA-driven neuronal differentiation in SH-SY5Y and SK-N-BE(2) 7 
induced a significant upregulation of ace2 mRNA, compared to undifferentiated cells 8 
(0.00071977.698e-005 vs. 0.0032340,0005701 in SH-SY5Y, p<0.05; 0.0044330.00107 vs. 9 
0.01072 0.001291 in SK-N-BE(2), p<0.05). Similarly, tmprss2 gene expression was 10 
significantly induced upon RA differentiation (0.00081776.422e-005 vs. 11 
0.0059940.0008207 in SH-SY5Y, p<0.05; 0.059640.02418 vs. 0.19560.008158 in SK-N-12 
BE(2), p<0.05, RA-differentiated cells vs. undifferentiated cells). No comparison was made 13 
between cell lines due to variable amounts of hprt housekeeping gene. The transcripts of 14 
cathepsin B and L were expressed at higher levels than hprt across all cell lines analyzed (Suppl. 15 
Fig. ure 1b). RA-induced differentiation produced a significant downregulation of ctsb mRNA 16 
in SK-N-BE(2) cells (27.612.809 vs. 21.351.185, p=0.05). Additionally, RA-induced 17 
differentiation produced a significant downregulation of ctsl mRNA in both SH-SY5Y and SK-18 
N-BE(2) (4.3170.8435 vs. 2.3110.1334, p<0.05; 10.991.412 vs. 4.9420.4085, p<0.05, RA-19 
differentiated cells vs. undifferentiated cells).  20 
RA-differentiated SH-SY5Y and SK-N-BE(2) were infected with SARS-CoV-2 at various 21 
MOIs during 2 or 24 hours. Viral RNA was revealed using fluorescent or chromogenic in situ 22 
hybridization (ish) targeting the gene S. After 24 hours at a MOI 5.0 of infection, ish signal was 23 
visualized in the cell bodies (black arrow), and to a certain extent in the neuritic processes 24 
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reflecting a fewer number of infected neuroblastoma cells (data not shown). In comparison, 1 
infection of highly permissive VeroE6 cells with a MOI of 0.1 during 24 hours produces a 2 
massive ish signal in the cytoplasmic compartment (Figure 1a2a). The entry of viral particles 3 
in neuroblastoma cell lines was quantified using a qRT-PCR targeting the SARS-CoV-2 gene 4 
E (Figure 1b2b). In SH-SY5Y, a 24 hours infection with MOIs 1.0 and 5.0 produced a 5 
significant amplification of SARS-CoV-2 RNA from lyzed cells, in a dose-dependent manner 6 
(respectively 1.3980.0976, p<0.05; 10.730.7595, p<0.001 when compared to mock 7 
condition). Noteworthy, the relative amount of gene E detected was higher when SH-SY5Y 8 
cells were infected at MOI 5.0 for 24 hours than for 2 hours (10.730.7595 vs. 5.7130.1542, 9 
p<0.001). In SK-N-BE(2) cells, only the highest MOI produced a significant infection at both 10 
timings, when compared to mock condition (respectively 1.4430.4262, p<0.001 and 11 
1.2840.09506, p<0.001). No difference of viral RNA amount was observed between 2 hours 12 
and 24 hours of infection. Given that neither transmitted light microscopy or qRT-PCR assays 13 
could provide a definitive answer about the viral entry – i.e. viral particles could be adsorbed 14 
at the cell surface non-specifically or receptor-bound – into host cells, we assessed the 15 
intracellular localization of viral RNA by confocal analysis.  The cytoskeleton of SH-SY5Y 16 
and SK-N-BE(2) cells was visualized using immunofluorescence against -tubulin while 17 
SARS-CoV-2 gene S was revealed using fluorescent ish (Figure 1c2c). In both cell lines, viral 18 
RNA was found in the same confocal plane as -tubulin network. Further analysis of 19 
fluorescence intensity confirmed that fluorescent peaks, corresponding to SARS-CoV-2 gene 20 
S (red) and to -tubulin (green), were overlapping (asterix in Suppl. Fig. 21).  21 
We next investigated a cytopathic effect of SARS-CoV-2 once inside the cells by measuring 22 
the length of neuritic processes grown by RA-differentiated SH-SY5Y (Figure 1d2d). No effect 23 
of SARS-CoV-2 infection was observed on the abilities of differentiated SH-SY5Y cells to 24 
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µm compared to 52.982.037 µm in mock condition, p=n.s.). In the same line, we sought to 1 
know whether SARS-CoV-2 could induce cell death in infected nervous cell lines. The 2 
apoptosis rate was quantified in VeroE6 cells and compared to infected SH-SY5Y and SK-N-3 
BE(2) cells (Figure 1e2e). While VeroE6 cells are highly permissive to SARS-CoV-2 (Figure 4 
1a2a) and are therefore used to amplify the virus, many of infected cells undergo apoptosis-5 
mediated cell death upon replication and/or release of viral particles. In VeroE6, the number of 6 
cleaved caspase-3 immunoreactive cells reached up to 25.332.603 % upon exposure to MOI 7 
5.0 during 24 hours, compared to 2.0000.5774 % in mock condition (p<0.001). Interestingly, 8 
neither SH-SY5Y or SK-N-BE(2) showed overt apoptosis upon infection with SARS-CoV-2, 9 
at any MOIs tested. For instance, the percentages of apoptotic cells were respectively 3.662.66 10 
% and 7.004.04 % at MOI 5.0 in SH-SY5Y and SK-N-BE(2) (p=n.s., compared to 2.500.88 11 
% in mock conditions). Overall, both neuroblastoma cell lines were much less prone to 12 
apoptosis than VeroE6 cells at comparable MOIs (two-way ANOVA, VeroE6 vs. SH-SY5Y: 13 
F(1,16)=44.21, p<0.001; VeroE6 vs. SK-N-BE(2) : F(1,16)=30.61, p<0.001). 14 
In order to evaluate the susceptibility of neural cell lines closer to a glial phenotype, U-87 MG 15 
and U-373 MG glioblastoma cell lines were infected with SARS-CoV-2 according to the same 16 
paradigm as neuroblastoma cells. At 2- or 24-hours post-infection, viral RNA was revealed 17 
using chromogenic in situ hybridization targeting the gene S (Figure 2a3a). Following 24 hours 18 
at MOI 5.0, infected cells showed obvious ish chromogenic deposits in the cell bodies as well 19 
as in the glial-like processes (inset in Figure 2a). The entry of viral particles in glioblastoma 20 
cells was also quantified using qRT-PCR (Figure 32b). In U-87 MG cells, a 24-hour infection 21 
produced a significant amplification of SARS-CoV-2 RNA, in a dose-dependent manner 22 
(0.3230.05743 for MOI 1.0, p<0.01 and 1.1250.07618 for MOI 5.0, p<0.001 compared to 23 
mock condition). Even though the levels of infection followed a similar profile at 2 hours post-24 
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at 2 hours of infection for MOI 5.0 (1.1250.07618 vs. 1.6170.1079, p<0.001).  In U-373 MG, 1 
only the highest MOI at 2 hours of infection led to a significant detection of viral RNA, 2 
compared to mock condition (2.1170.2568 vs. 0.00.0 undetected, p<0.001) (Figure 2b3b). A 3 
24-hour infection produced a significant amplification in a dose-dependent manner 4 
(0.94330.0382 for MOI 1.0, p<0.01 and 3.6710.4731 for MOI 5.0, p<0.001 compared to 5 
mock condition). At MOI 5.0, a longer infection time led to increased amount of gene E 6 
detected in U-373 MG (2.1170.2568 at 2 hours vs. 3.6710.4731 at 24 hours, p<0.001). 7 
U-87 and U-373 cell lines are both considered as glioblastoma cells comprising a heterogeneous 8 
mixture of morphologically, biochemically and functionally distinct cancer cells. For instance, 9 
they are both classified as astrocytoma cells but differ in terms of GFAP expression. Grown on 10 
uncoated plastic culture dishes, U-87 MG cells are GFAP
low
 expressing cells whereas U-373 11 
MG cells are GFAP
high
-expressing cells (Figure 2c3c). Both cell lines, no matter they express 12 
low or high GFAP levels, are susceptible to SARS-CoV-2 infection. U-87 and U-373 also differ 13 
in glutamate uptake abilities, even though all glioma cell lines showed impaired glutamate 14 
uptake compared to normal human astrocytes (Ye and Sontheimer, 1999). While U-87 cells 15 
have lost this ability (data not shown), U-373 MG cells internalized glutamate upon addition of 16 
200 µM of glutamate in the medium (111.43.452 µM compared to 224.78.722 µM in basal 17 
medium without cells, p<0.001) (Figure 2d3d). Infection with various MOIs of SARS-CoV-2 18 
during 24 hours did not impact U-373 cells in their glutamate uptake abilities (one-way 19 
ANOVA, p= 0.4668 mock vs. MOI 0.1; p=0.0955 mock vs. MOI 1.0; p=0.9664 mock vs. MOI 20 
5.0). Finally, SARS-CoV-2 cytopathic effect on glioblastoma cells was evaluated by counting 21 
the number of cleaved caspase-3 positive cells at 24 hours of infection (Figure 2e3e). Infected 22 
U-87 or U-373 did not show more apoptosis at any MOI tested than mock condition. For 23 
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MOI 5.0 in U-87 and U-373 (p=n.s., compared to 2.830.83 % in mock conditions). Overall, 1 
glioblastoma cell lines were much less prone to apoptotic cell death than VeroE6 cells at 2 
comparable MOIs (two-way ANOVA, VeroE6 vs. U-87 MG: F(1,16)=38.70, p<0.001; VeroE6 3 
vs. U-373 MG : F(1,16)=38.78, p<0.001).  4 
 5 
 6 
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3. Discussion 1 
Our main findings are that SARS-CoV-2 is able to invade neuroblastoma and glioblastoma cell 2 
lines, without exerting major cytopathic effect on either neuron-like morphology or on 3 
functional glutamate uptake, and without inducing obvious apoptosis. Although the viral entry-4 
dependency on common entry genes was not investigated, a basal expression of ace2, tmprss2, 5 
cathepsin B and cathepsin L transcripts was detected in all cell lines. Noteworthy, RA-6 
differentiated neuroblastoma cells upregulated the gene expression of surface receptors such as 7 
ace2 and tmprss2. The definitive entry mechanisms inside nervous cells are still debated and 8 
existence of alternative surface receptors that might be hijacked cannot be ruled out, as it is 9 
described for SARS‐CoV and some epithelial cells or immune cells e.g. CD147/BSG, 10 
CD26/DPP4 (Radzikowska et al., 2020).  11 
Our experimental design allows to conclude that neuroblastoma and glioblastoma cells are 12 
modestly susceptible to SARS-CoV-2 infection, based on the high MOI needed to infect cells. 13 
In comparison to recent studies, human brain organoids and neurospheres were respectively 14 
infected with MOIs of 10.0 and 0.1 (Bullen et al., 2020; Zhang et al., 2020). At early infection 15 
timings (24h), neuroblastoma and glioblastoma cells were not as permissive as VeroE6 16 
epithelial cells. So far, contradictory results are reported about the SARS-CoV-2 replication 17 
into human neurons. While one study showed that SARS-CoV-2 entered neurons from brain 18 
organoids but did not replicate (Ramani et al., 2020), in two studies genomic viral material was 19 
found in the supernatant at higher level several hours post-infection than at the time zero of 20 
infection, which supports the release of new viral particles (Bullen et al., 2020; Zhang et al., 21 
2020). Intriguingly, we did not observe major SARS-CoV-2 cytopathic effect on any cell lines, 22 
unlike what was described in infected brain neurospheres or despite the evidences of neuronal 23 
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might be explained by a better resistance of tumor cell lines towards SARS-CoV-2 infection or 1 
a too short timing for apoptosis analysis. 2 
Bearing in mind the limitation that in situ hybridization – and not immunofluorescence nor 3 
electron microscopy - was used throughout this study to detect SARS-CoV-2, our confocal 4 
images comforted the intracellular localization of viral RNA. Interestingly, viral RNA was 5 
distributed in both soma, and neuron-like or glial-like extensions. So far, we did not investigate 6 
whether this distribution was due to random internalization along the cell membrane or whether 7 
internalized viral particles were able to be transported inside/along the cell processes. This last 8 
concept is relevant for deciphering the CNS entry routes. Among the entry pathways, the 9 
retrograde transport along nerve fibers from peripheral infected tissues (i.e. nasal cavity) or the 10 
hematogenous pathway across the blood-brain barrier (BBB) are being demonstrated 11 
(Meinhardt et al., 2020; Uversky et al., 2020). From our images showing SARS-CoV-2 RNA 12 
in the cell processes, it is tempting to hypothesize that neuron-like or glial-like cells might 13 
internalize viral particles at their farthest cell extension and then, using intracellular trafficking, 14 
carry them back to the soma. Corollary, SARS-CoV-2 might penetrate the CNS gate by first 15 
invading brain endothelial cells or following BBB disruption, then being caught at the 16 
perivascular astrocytic processes (Uversky et al., 2020). This hypothesis is supported by 17 
ultrastructural findings from autopsied COVID-19 patients, where authors captured viral 18 
particles at the endothelial-astrocyte interface (Bulfamante et al., 2020; Paniz-Mondolfi et al., 19 
2020). This passage would even be eased in the context of an important systemic inflammation 20 
that includes cytokines known to compromise BBB integrity (Uversky et al., 2020). 21 
This study on SARS-CoV-2 cell tropism is complementary to those using human pluripotent 22 
stem cell-based platform (Yang et al., 2020). Infection of neuroblastoma or glioblastoma cells 23 
might serve as an easy and low-cost model for testing drugs that interfere with viral entry, e.g. 24 
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4. Experimental Procedure 1 
4.1. Cell culture 2 
The SH-SY5Y neuroblastoma cell line, U-87 MG and U-373 MG glioblastoma cell lines were 3 
kindly provided by Profs. Jean-Pierre Brion and Karelle Leroy (Université Libre de Bruxelles, 4 
BE). The SK-N-BE(2) neuroblastoma cell line was a kind gift from Prof. Marielle Boonen 5 
(Université de Namur, BE). All cell lines were used between passage 15 and 25. They were 6 
maintained in DMEM/F12 (Life Technologies, Grand Island, NY, USA) supplemented with 10 7 
% fetal bovine serum (Sigma-Aldrich, Overijse, BE) and penicillin/streptomycin (Sigma-8 
Aldrich, Overijse, BE / Millipore, USA). Cells were grown in a sterile incubator at 37 °C, 95 9 
% air humidity and 5 % CO2 concentration. Culture medium was changed twice a week, 10 
depending on cell density, and cells were passaged for further cultivation or differentiation 11 
experiment at 80 – 90 % confluency. For passaging, cells were trypsinized using 0.05 % 12 
Trypsin/EDTA during 2 minutes, washed in medium and spun down at 130 g for 7 minutes and 13 
further split at a ratio 1:10. For differentiation experiment, SH-SY5Y and SK-N-BE(2) cells 14 
were seeded at a density of 20,000 cells per cm2, on glass coverslips pre-coated with 0.1 mg/ml 15 
Poly-L-lysine (Sigma-Aldrich, Overijse, BE). A differentiation protocol was applied based on 16 
7 day-exposure to 10 µM all-trans-retinoic acid (RA) (Sigma-Aldrich, Overijse, BE) added in 17 
low-serum medium (DMEM/F12 + 2% FBS + penicillin/streptomycin). RA-driven 18 
differentiation was initiated 24 h after seeding and fresh medium was replaced everyday up to 19 
day 7. Vero cells, clone E6 (VeroE6), were used to amplify a purified SARS-CoV-2 strain 20 
isolated from a Belgian COVID-19 patient.  21 
4.2. Infection with SARS-CoV-2 22 
All infections or viral amplification were performed in a biosafety level-3 laboratory 23 
(Université de Namur, BE). The SARS-CoV-2 isolate was kindly provided by Prof. Piet Maes 24 
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supernatant from infected Vero E6 cells. Neuroblastoma or glioblastoma cells were plated at a 1 
density of 20,000 cells per cm2 in a 24-well plate for in situ hybridization or a 12-well plate for 2 
gene expression studies. Cells were infected during 2- or 24- hours using a multiplicity-of-3 
infection (MOI) of 0.1, 1.0 or 5.0 in low-serum medium. For mock condition, cells were 4 
incubated with the low-serum medium-only. At the end of infection, culture medium was 5 
carefully discarded. Cells were thoroughly washed three times with PBS and either lyzed in 6 
TriZol or chemically-fixed with 4% paraformaldehyde, ensuring virus inactivation.    7 
4.3. RNA isolation and qRT-PCR 8 
Cells were homogenized in 1 mL of Trizol reagent and total RNA was further isolated according 9 
to manufacturer’s instructions (Life Technologies, Bleiswijk, NL). RNA concentrations were 10 
measured using a spetrophotometer Nanodrop 1000 (Thermo Scientific, Bleiswijk, NL). Total 11 
RNAs (1µg), including viral and human RNAs, were reverse-transcribed using the Super Script 12 
II RNase H reverse transcriptase kit according to manufacturer’s instructions (Invitrogen, 13 
Merelbeke, BE). cDNA was used to amplify SARS-CoV-2 gene E with Takyon Taqman kit 14 
and human genes with Takyon SYBR Green kit (Eurogentec, Liège, BE) in a Light Cycler 96 15 
device (Roche Diagnostics, Mannheim, DE) (Coupeau et al., 2020). Primer sequences are listed 16 
in Table 1. Relative gene expression was computed using the Cq method with hprt as 17 
housekeeping gene. 18 
4.4. in situ hybridization and immunofluorescence 19 
Coverslips were fixed in cold 4% paraformaldehyde during 15 20 minutes and then washed and 20 
stored in PBS at 4°C. Fixed cells were used within one-week post-fixation. Expression of 21 
SARS-CoV-2 gene S was detected according to manufacturer’s kit instructions (RNAScope, 22 
Advanced Cell Diagnostics, Bio-techne, Abingdon, UK) and by using a specific target probe 23 
(RNAscope Probe-V-nCoV2019-S, #848561, Bio-techne, Abingdon, UK). Briefly, cells were 24 
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peroxidases were blocked with hydrogen peroxide for 10 min followed by 2 washes in PBS. 1 
Cells were then incubated with RNAScope® Protease III (Advanced Cell Diagnostics Inc, 2 
Hayward, USA) for 10 min. and subsequently washed in PBS. Samples were incubated with 3 
the probe specifically targeting SARS-CoV-2 gene S mRNA (RNAScope, #422511, Advanced 4 
Cell Diagnostics, Bio-techne, Abingdon, UK) for 2 hours at 40°C and then washed for 2min in 5 
RNAScope® wash buffer (Advanced Cell Diagnostics, Bio-techne, Abingdon, UK). 6 
Amplification rounds 1-6 alternated from 30 to 15 min at 40°C. Between each amplification 7 
round, samples were washed with RNAScope® wash buffer. Detection of probe signals was 8 
performed by incubating samples with alkaline phosphatase (solution of RNAScope® Fast B 9 
and A ratio 1:60) for 10 min. at room temperature. Samples were then washed in milliQ water. 10 
Following ish, samples were either counterstained with hematoxylin (Sigma-Aldrich, Overijse, 11 
BE), dried for 30 min. at 60°C and mounted using VectaMount® (Vector Laboratories, 12 
Burlingame, USA) or fluorescently stained according to the protocol below. 13 
For ish/immunofluorescence multiplexing, coverslips were further washed 5 min at RT in PBS. 14 
Non-specific binding was blocked in a PBS-BSA 1% for 30min at RT. Then, samples were 15 
incubated with primary antibodies in PBS-BSA 1 % buffer overnight at RT: α-tubulin (1:500, 16 
T-5168, Sigma-Aldrich); GFAP (1:1000, G-3893, Sigma-Aldrich); cleaved caspase-3 (1:1000, 17 
#9664, Cell Signaling). After that, samples were washed 3X5 min with PBS-BSA 1%. 18 
Fluorophore-coupled secondary antibodies alexa fluor® 488 goat anti-mouse IgG 1:200 19 
(#A11001, Life Technologies, Oregon, USA) or goat anti-rabbit IgG 1:200 (#A11008, Life 20 
Technologies, Oregon, USA) in PBS-BSA1% were applied on their respective tissue sections 21 
and incubated for 30 min at RT. Afterwards, they were washed 3X5 min with PBS-BSA 1% 22 
and cell nuclei were stained in a solution of Hoechst 33258 (Life Technologies, Oregon, USA). 23 
Finally, after 1X5 min wash with PBS-BSA 1% and 2X5 min with PBS, tissue sections were 24 
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BX63 epifluorescence microscope equipped with SC50 camera for brightfield and XM10 1 
camera for fluorescence.  2 
4.5. Image analysis 3 
Intracellular virus distribution was analyzed using a Leica TCS SP5 confocal microscope. 4 
Individual cells among those that were in focal field were randomly chosen and the spatial 5 
relationship between SARS-CoV-2 ish probe signal and cytoskeleton network (-tubulin) was 6 
visually assessed. For each condition, 20 infected cells were at least acquired. All of the images 7 
were recorded at the same laser and multiplier settings.  8 
For neurite length assessment, multiple representative brightfields of SH-SY5Y cells were 9 
imaged using an inverted microscope Olympus CKX41 equipped with EP50 camera. The 10 
channels were extracted to grey scale and the length of 5 to 10 neurites per field was traced and 11 
measured, thereafter, from the distal end of neuron growth-cone, using the neurite tracer plugin 12 
NeuronJ (ImageJ add-on software), according to published protocol (Pemberton et al., 2018). 13 
From the images, at least 35 neurites per condition were quantified.  14 
For the analysis of caspase-3 immunolabeling, 100 cells per experimental condition were 15 
randomly acquired based on Hoescht nuclei counterstaining. The number of immunoreactive 16 
cleaved caspase-3+ cells was manually and blinded counted, and further related to 100 cell 17 
nuclei.  18 
4.6. Glutamate Uptake Assay 19 
The assay was adapted from Mahmoud et al. (Mahmoud et al., 2019). Briefly, 100,000 cells 20 
were seeded in each well of a 96-well plate, and washed 2 times with Hank’s Balanced Salt 21 
Solution (HBSS) containing Ca2+ and Mg2+: 1.26 mM CaCl2, 5.36 mM KCl, 0.44 mM 22 
KH2PO4, 0.811 mM MgSO4, 137 mM NaCl, 0.336 mM Na2HPO4, 4.166 mM NaHCO3, and 23 
5.55 mM d-glucose. Cells were then incubated with HBSS containing 200 µM L-glutamic acid 24 
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glutamate concentration in the medium was measured using a glutamate colorimetric assay kit 1 
according to the manufacturer’s instructions (#MAK004, Sigma-Aldrich, Overijse, BE). Total 2 
extracellular glutamate reflects the sum of glutamate uptake and release activities.  3 
4.7. Statistics 4 
Unless specified, all results were expressed as mean values ± Standard Error of Mean (SEM). 5 
Mann–Whitney was used to assess statistical significance between two groups. For multiple 6 
comparisons (≥3 groups), one-way non-parametric ANOVA test followed by Kruskal-Wallis 7 
post-hoc analysis was used to compare each MOI condition. When groups had to be compared 8 
based on two parameters (e.g. cell type and MOI), two-way non-parametric ANOVA test 9 
followed by Dunnett’s post-hoc analysis was used. The level of significance was set at p<0.05. 10 
The statistical analyses were performed using the software GraphPad Prism version 7 11 
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Table 1. Primer and probe sequences for qRT-PCR. 14 
 15 


































































Bielarz et al.  SARS-CoV-2 infection of neural cell lines 
18 
 
Figure captions (ALL FIGURES IN COLOR) 1 
Suppl. Figure. 1. Relative quantification of SARS-CoV-2 entry genes in human neural cell 2 
lines: ace2 and tmprss2 (a); ctsb and ctsl (b). Ct cycles for entry genes were normalized to Ct 3 
cycles of human hprt and relative expression data were expressed as 2e-Ct. Statistical 4 
significance was assessed using Mann-Whitney only on SH-SY5Y and SK-N-BE(2) cells with 5 
or without  RA-based differentiation. *p<0.05. Each box plots the median and extends from the 6 
25th to 75th percentiles. Whiskers shows the min. and max. values. n=4 independent samples 7 
per condition. 8 
 9 
Figure 12. Chromogenic or fluorescent in situ hybridization (ish) using SARS-CoV-2 gene S 10 
probe (nCoV2019-S, red) were applied on RA-differentiated SH-SY5Y and SK-N-BE(2) cells 11 
exposed to SARS-CoV-2 at MOI 5.0 during 24 hours or to mock condition (a). Nuclei were 12 
counterstained with Hoechst (blue). Scale bar represents 50 µm. Viral RNA was detected in the 13 
cell body compartment of infected cells (black arrow) as well as along the neuritic processes 14 
(black arrowheads). Scale bar represents 10 µm. In comparison, infection of epithelial VeroE6 15 
cells with a lower MOI (0.1) of SARS-CoV-2 produced a massive ish signal in the cytoplasmic 16 
compartment (upper right panel). Scale bar represents 20 µm. Quantification of SARS-CoV-2 17 
gene E relative abundance in infected SH-SY5Y and SK-N-BE(2) according to various MOIs 18 
and timings of infection (b). Ct cycles for gene E were normalized to Ct cycles of human hprt 19 
and relative expression data were expressed as 2e-Ct. Statistical significance was calculated 20 
using a two-way ANOVA comparing each MOI and each timing. *p<0.05; ***p<0.001 for 21 
comparisons between each MOI, 
###
p<0.001 for comparisons between 2 hours and 24 hours of 22 
infection.  n=3 independent samples for each condition. Representative multiplex nCoV2019S 23 
ish (red)/ -tubulin (green) immunofluorescence images showed that viral RNA was in the 24 
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when cells were infected at MOI 5.0 during 24 hours (c). Scale bar represents 25 µm. 1 
Orthogonal views from z-stack reconstruction confirmed the intracellular localization of SARS-2 
CoV-2 RNA signal. At 24 hours of infection, SARS-CoV-2 cytopathic effect was assessed by 3 
measuring the length of neuritic processes grown by RA-differentiated SH-SY5Y cells (d). 4 
Statistical significance was calculated using a one-way ANOVA comparing each MOI to mock 5 
condition. N=35-39 neurites counted per condition. At 24 hours of infection, SARS-CoV-2 6 
cytopathic effect was assessed by counting the number of cleaved caspase-3 immunoreactive 7 
SH-SY5Y or SK-N-BE(2) cells, and compared to MOI-matched VeroE6 cells (e). Statistical 8 
significance was calculated using a two-way ANOVA comparing each MOI and each cell type. 9 




p<0.001 for comparisons between MOI. N=100 cell nuclei counted per condition. 11 
Abbreviations: MOI, multiplicity-of-infection; n.d., not detected; n.s., not significant. 12 
 13 
Figure 23. Chromogenic in situ hybridization (ish) using SARS-CoV-2 gene S probe 14 
(nCoV2019-S) was applied on U-87 MG and U-373 MG cells exposed to SARS-CoV-2 at MOI 15 
5.0 during 24 hours or to mock condition (a). Scale bar represents 20 µm. Viral RNA was 16 
detected in the cell body compartment of infected cells as well as in the glial-like processes 17 
(inset in the upper right panel). Quantification of SARS-CoV-2 gene E relative abundance in 18 
infected SH-SY5Y and SK-N-BE(2) according to various MOIs and timings of infection (b). 19 
Ct cycles for gene E were normalized to Ct cycles of human hprt and relative expression data 20 
were expressed as 2e-Ct. Statistical significance was calculated using a two-way ANOVA 21 
comparing each MOI and each timing. **p<0.01; ***p<0.001 for comparisons between each 22 
MOI, 
###
p<0.001 for comparisons between 2 hours and 24 hours of infection. N=3 independent 23 
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immunofluorescence images showed SARS-CoV-2 abilities to infect both GFAP
low
-1 
expressing cells (U-87 MG) and GFAP
high
-expressing cells (U-373 MG), upon infection with 2 
MOI 5.0 during 24 hours (c). Scale bar represents 20 µm. At 24 hours of infection, SARS-CoV-3 
2 cytopathic effect was assessed by quantifying the ability of U-373 MG cells to take up 4 
extracellular glutamate added to the culture supernatant (200 µM) (d). Infected U-373 MG cells 5 
were able to pump up glutamate from supernatant as efficiently as non-infected cells (p=n.s.). 6 
Statistical significance was calculated using a one-way ANOVA comparing each MOI to mock 7 
condition. N=6 independent samples per condition. At 24 hours of infection, SARS-CoV-2 8 
cytopathic effect was assessed by counting the number of cleaved caspase-3 immunoreactive 9 
U-87 MG or U-373 MG cells, and compared to MOI-matched VeroE6 cells (e). Statistical 10 
significance was calculated using a two-way ANOVA comparing each MOI and each cell type. 11 




p<0.001 for comparisons between MOI. n=100 cell nuclei counted per condition. 13 
Abbreviations: MOI, multiplicity-of-infection; n.d., not detected; n.s., not significant. 14 
 15 
Suppl. Fig. 1. Relative quantification of SARS-CoV-2 entry genes in human neural cell lines: 16 
ace2 and tmprss2 (a); ctsb and ctsl (b). Ct cycles for entry genes were normalized to Ct cycles 17 
of human hprt and relative expression data were expressed as 2e-Ct. Statistical significance 18 
was assessed using Mann-Whitney only on SH-SY5Y and SK-N-BE(2) cells with or without  19 
RA-based differentiation. *p<0.05. Each box plots the median and extends from the 25th to 20 
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Suppl. Fig. 21. Representative confocal images of SARS-CoV-2 infected neuroblastoma cells, 1 
labeled for nCoV2019-S (red), -tubulin (green) and counterstained with Hoechst (blue nuclei). 2 
Analysis of peak fluorescence intensity from one confocal plane shows the co-localization of 3 
red and green peaks at several distances (asterix) along the region-of-interest. 4 
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Modelling cell infection in-a-dish can represent a useful tool to understand the susceptibility of 1 
different cell types towards severe acute respiratory coronavirus-2 (SARS-CoV-2) and to 2 
decipher its neurotropism. In this perspective, retinoic acid (RA)-differentiated neuroblastoma 3 
cell lines, SH-SY5Y and SK-N-BE(2) and glioblastoma cell lines, U-87 MG and U-373 MG, 4 
were infected with a SARS-CoV-2 strain, at various multiplicity-of-infection (MOI). We first 5 
demonstrated that the common entry genes - needed for invading epithelial cells - were 6 
expressed. RA-differentiation induced an upregulation of ace2 and tmprss2 gene expression 7 
while inducing downregulation of ctsb and ctsl. Using in situ hybridization and confocal 8 
analysis, SARS-CoV-2 gene S RNA was detected intracellularly at MOI 5.0, and localized in 9 
both soma and neuritic-like or glial-like processes. The infection was confirmed by 10 
quantification of viral gene E RNA and showed a dose-dependency, with few infected cells at 11 
MOI 0.1. After 24 hours of infection, no cytopathic effect was observed in SH-SY5Y abilities 12 
to maintain neuritic processes or in U-373 MG for the uptake of glutamate. Unlike the 13 
permissive Vero E6 cells, no significant apoptosis death was detected following SARS-CoV-2 14 
infection of neuroblastoma or glioblastoma cells.  This study demonstrates the susceptibility of 15 
neuronal- and glial-like cell lines towards SARS-CoV-2 infection at high MOIs. Once inside 16 
the cells, the virus does not seem to rapidly replicate nor exert major cytopathic effect. Overall, 17 
our results strengthen the idea that SARS-CoV-2 has a tropism for nervous cells that express 18 
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SARS-CoV  severe acute respiratory syndrome coronavirus 6 
SARS-CoV-2  severe acute respiratory syndrome coronavirus-2 7 
COVID-19  coronavirus disease 2019 8 
ace2   angiotensin-converting enzyme 2 9 
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ctsl   cathepsin L 12 
MOI   multiplicity-of-infection 13 
ish   in situ hybridization 14 
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* Neuroblastoma and glioblastoma cells express SARS-CoV-2 entry genes 21 
* Neuroblastoma and glioblastoma cell lines are susceptible to SARS-CoV-2 infection 22 
* Viral RNA is detected intracellularly in both soma and cell’s extensions 23 
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1. Introduction 1 
Most of the time, the infection with severe acute respiratory syndrome coronavirus 2 (SARS-2 
CoV-2) causes respiratory symptoms, known as coronavirus disease 2019 (COVID-19), 3 
although a minority of patients are at risk of developing a severe form with extrapulmonary 4 
involvements (for review (Gupta et al., 2020)). Severely SARS-CoV-2-affected patients are 5 
more likely to develop neurologic symptoms (e.g. headache, epilepsy, confusion, nausea and 6 
vomiting) than patients with a mild form of COVID-19 (Asadi-Pooya and Simani, 2020; Mao 7 
et al., 2020a; Paterson et al., 2020). Among the worst neurologic cases, viral encephalitis, 8 
necrotizing encephalopathy, acute myelitis or Guillain-Barré syndrome were reported (Chen et 9 
al., 2020; Kilinc et al., 2020; Mao et al., 2020a; Moriguchi et al., 2020; Poyiadji et al., 2020; 10 
Zhao et al., 2020). Intriguingly, some patients developed neurologic symptoms even prior to 11 
any respiratory manifestation. In one retrospective study, up to 88% among the severe patients 12 
showed acute cerebrovascular diseases associated with impaired consciousness (Mao et al., 13 
2020b). Neuro-imaging supports substantial brain damages in both COVID-19 survivors and 14 
non-survivors (Coolen et al., 2020; Helms et al., 2020; Zanin et al., 2020). Increasing evidences 15 
show the presence of SARS-Cov-2 in brain post-mortem tissue (Bulfamante et al., 2020; Paniz-16 
Mondolfi et al., 2020; Puelles et al., 2020; Song et al., 2021), even though the mechanisms and 17 
routes of CNS entry are still elusive. 18 
SARS-CoV-2 belongs to the same beta‐coronaviruses family as SARS-CoV (2003 China 19 
outbreak) and shares up to 79,6% pairwise identities on a genomic level with its cousin (Lu et 20 
al., 2020). SARS-CoV-2 also shares common entry mechanisms used to invade target cells, 21 
including the binding of the spike (S) protein to human ACE2 receptor. S protein sequence was 22 
found to be approximately 77% homologous between SARS-CoV-2 and SARS-CoV. SARS-23 
CoV-2 entry also depends on TMPRSS2 protease activity, which helps at ACE2 cleavage and 24 
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al., 2020). Alternatively, cathepsin B or L may be able to substitute for TMPRSS2 in early 1 
endosomes upon endocytosis. ACE2 and TMPRSS2 have been detected at high expression 2 
levels in nasal, bronchial epithelium, as well as in alveolar epithelium (mostly type II 3 
pneumocytes), which explains the central respiratory pathology (Ortiz et al., 2020). Previously, 4 
neuro-invasion abilities of SARS-CoV have been firmly demonstrated on both patients and 5 
experimental animal models (Gu et al., 2005; Netland et al., 2008). Evidence from transgenic 6 
humanized ACE2 mice showed that SARS-CoV is able to enter the nervous system through the 7 
neuro-olfactory epithelium. It is then carried along the olfactory nerve up to the olfactory bulb, 8 
where it starts to spread to neighboring nervous cells (Netland et al., 2008). Similar SARS-9 
CoV-2 neurotropic properties and CNS entry routes are under investigation. Of note, infected 10 
cells from the olfactory neuro-epithelium are suggested as gateways to central nervous system 11 
invasion in some individuals with COVID-19 (Cantuti-Castelvetri et al., 2020; Meinhardt et al., 12 
2020). Such an entry route was demonstrated as plausible in transgenic humanized ACE2 mice 13 
following experimental intranasal instillation of SARS-CoV-2 (Kumari et al., 2021).  14 
So far,  in vitro data showed the permissiveness of U-251 glioblastoma cell line to SARS-CoV-15 
2 infection (Chu et al., 2020). Recently, evidences from five independent groups converge to 16 
show that human neural progenitor cells, grown either as neurospheres or as brain organoids, 17 
are susceptible to SARS-CoV-2 infection (Bullen et al., 2020; Ramani et al., 2020; Song et al., 18 
2021; Yang et al., 2020; Zhang et al., 2020). In the present report, we aim at investigating the 19 
susceptibility of neuroblastoma and glioblastoma cell lines towards SARS-CoV-2 infection. 20 
These respective neuron-like and glial-like cells might represent useful tools to decipher the 21 
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2. Results 1 
Before infecting the various neural cell lines with a Belgian SARS-CoV-2 strain, we sought to 2 
explore their expression level of entry genes, encoding proteins commonly needed by SARS-3 
CoV-2 for invading human host cells. The transcripts for ace2 and tmprss2 genes were detected 4 
in both neuroblastoma (SH-SY5Y and SK-N-BE(2)) and both glioblastoma (U-87 MG and U-5 
373 MG) cells, however in lower amounts than those of hprt housekeeping gene (Figure 1a). 6 
Interestingly, RA-driven neuronal differentiation in SH-SY5Y and SK-N-BE(2) induced a 7 
significant upregulation of ace2 mRNA, compared to undifferentiated cells 8 
(0.00071977.698e-005 vs. 0.0032340,0005701 in SH-SY5Y, p<0.05; 0.0044330.00107 vs. 9 
0.01072 0.001291 in SK-N-BE(2), p<0.05). Similarly, tmprss2 gene expression was 10 
significantly induced upon RA differentiation (0.00081776.422e-005 vs. 11 
0.0059940.0008207 in SH-SY5Y, p<0.05; 0.059640.02418 vs. 0.19560.008158 in SK-N-12 
BE(2), p<0.05, RA-differentiated cells vs. undifferentiated cells). No comparison was made 13 
between cell lines due to variable amounts of hprt housekeeping gene. The transcripts of 14 
cathepsin B and L were expressed at higher levels than hprt across all cell lines analyzed (Figure 15 
1b). RA-induced differentiation produced a significant downregulation of ctsb mRNA in SK-16 
N-BE(2) cells (27.612.809 vs. 21.351.185, p=0.05). Additionally, RA-induced 17 
differentiation produced a significant downregulation of ctsl mRNA in both SH-SY5Y and SK-18 
N-BE(2) (4.3170.8435 vs. 2.3110.1334, p<0.05; 10.991.412 vs. 4.9420.4085, p<0.05, RA-19 
differentiated cells vs. undifferentiated cells).  20 
RA-differentiated SH-SY5Y and SK-N-BE(2) were infected with SARS-CoV-2 at various 21 
MOIs during 2 or 24 hours. Viral RNA was revealed using fluorescent or chromogenic in situ 22 
hybridization (ish) targeting the gene S. After 24 hours at a MOI 5.0 of infection, ish signal was 23 
visualized in the cell bodies (black arrow), and to a certain extent in the neuritic processes 24 
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a fewer number of infected neuroblastoma cells (data not shown). In comparison, infection of 1 
highly permissive VeroE6 cells with a MOI of 0.1 during 24 hours produces a massive ish 2 
signal in the cytoplasmic compartment (Figure 2a). The entry of viral particles in neuroblastoma 3 
cell lines was quantified using a qRT-PCR targeting the SARS-CoV-2 gene E (Figure 2b). In 4 
SH-SY5Y, a 24 hours infection with MOIs 1.0 and 5.0 produced a significant amplification of 5 
SARS-CoV-2 RNA from lyzed cells, in a dose-dependent manner (respectively 1.3980.0976, 6 
p<0.05; 10.730.7595, p<0.001 when compared to mock condition). Noteworthy, the relative 7 
amount of gene E detected was higher when SH-SY5Y cells were infected at MOI 5.0 for 24 8 
hours than for 2 hours (10.730.7595 vs. 5.7130.1542, p<0.001). In SK-N-BE(2) cells, only 9 
the highest MOI produced a significant infection at both timings, when compared to mock 10 
condition (respectively 1.4430.4262, p<0.001 and 1.2840.09506, p<0.001). No difference of 11 
viral RNA amount was observed between 2 hours and 24 hours of infection. Given that neither 12 
transmitted light microscopy or qRT-PCR assays could provide a definitive answer about the 13 
viral entry – i.e. viral particles could be adsorbed at the cell surface non-specifically or receptor-14 
bound – into host cells, we assessed the intracellular localization of viral RNA by confocal 15 
analysis.  The cytoskeleton of SH-SY5Y and SK-N-BE(2) cells was visualized using 16 
immunofluorescence against -tubulin while SARS-CoV-2 gene S was revealed using 17 
fluorescent ish (Figure 2c). In both cell lines, viral RNA was found in the same confocal plane 18 
as -tubulin network. Further analysis of fluorescence intensity confirmed that fluorescent 19 
peaks, corresponding to SARS-CoV-2 gene S (red) and to -tubulin (green), were overlapping 20 
(asterix in Suppl. Fig. 1).  21 
We next investigated a cytopathic effect of SARS-CoV-2 once inside the cells by measuring 22 
the length of neuritic processes grown by RA-differentiated SH-SY5Y (Figure 2d). No effect 23 
of SARS-CoV-2 infection was observed on the abilities of differentiated SH-SY5Y cells to 24 
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µm compared to 52.982.037 µm in mock condition, p=n.s.). In the same line, we sought to 1 
know whether SARS-CoV-2 could induce cell death in infected nervous cell lines. The 2 
apoptosis rate was quantified in VeroE6 cells and compared to infected SH-SY5Y and SK-N-3 
BE(2) cells (Figure 2e). While VeroE6 cells are highly permissive to SARS-CoV-2 (Figure 2a) 4 
and are therefore used to amplify the virus, many of infected cells undergo apoptosis-mediated 5 
cell death upon replication and/or release of viral particles. In VeroE6, the number of cleaved 6 
caspase-3 immunoreactive cells reached up to 25.332.603 % upon exposure to MOI 5.0 during 7 
24 hours, compared to 2.0000.5774 % in mock condition (p<0.001). Interestingly, neither SH-8 
SY5Y or SK-N-BE(2) showed overt apoptosis upon infection with SARS-CoV-2, at any MOIs 9 
tested. For instance, the percentages of apoptotic cells were respectively 3.662.66 % and 10 
7.004.04 % at MOI 5.0 in SH-SY5Y and SK-N-BE(2) (p=n.s., compared to 2.500.88 % in 11 
mock conditions). Overall, both neuroblastoma cell lines were much less prone to apoptosis 12 
than VeroE6 cells at comparable MOIs (two-way ANOVA, VeroE6 vs. SH-SY5Y: 13 
F(1,16)=44.21, p<0.001; VeroE6 vs. SK-N-BE(2) : F(1,16)=30.61, p<0.001). 14 
In order to evaluate the susceptibility of neural cell lines closer to a glial phenotype, U-87 MG 15 
and U-373 MG glioblastoma cell lines were infected with SARS-CoV-2 according to the same 16 
paradigm as neuroblastoma cells. At 2- or 24-hours post-infection, viral RNA was revealed 17 
using chromogenic in situ hybridization targeting the gene S (Figure 3a). Following 24 hours 18 
at MOI 5.0, infected cells showed obvious ish chromogenic deposits in the cell bodies as well 19 
as in the glial-like processes (inset in Figure 2a). The entry of viral particles in glioblastoma 20 
cells was also quantified using qRT-PCR (Figure 3b). In U-87 MG cells, a 24-hour infection 21 
produced a significant amplification of SARS-CoV-2 RNA, in a dose-dependent manner 22 
(0.3230.05743 for MOI 1.0, p<0.01 and 1.1250.07618 for MOI 5.0, p<0.001 compared to 23 
mock condition). Even though the levels of infection followed a similar profile at 2 hours post-24 
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at 2 hours of infection for MOI 5.0 (1.1250.07618 vs. 1.6170.1079, p<0.001).  In U-373 MG, 1 
only the highest MOI at 2 hours of infection led to a significant detection of viral RNA, 2 
compared to mock condition (2.1170.2568 vs. 0.00.0 undetected, p<0.001) (Figure 3b). A 3 
24-hour infection produced a significant amplification in a dose-dependent manner 4 
(0.94330.0382 for MOI 1.0, p<0.01 and 3.6710.4731 for MOI 5.0, p<0.001 compared to 5 
mock condition). At MOI 5.0, a longer infection time led to increased amount of gene E 6 
detected in U-373 MG (2.1170.2568 at 2 hours vs. 3.6710.4731 at 24 hours, p<0.001). 7 
U-87 and U-373 cell lines are both considered as glioblastoma cells comprising a heterogeneous 8 
mixture of morphologically, biochemically and functionally distinct cancer cells. For instance, 9 
they are both classified as astrocytoma cells but differ in terms of GFAP expression. Grown on 10 
uncoated plastic culture dishes, U-87 MG cells are GFAP
low
 expressing cells whereas U-373 11 
MG cells are GFAP
high
-expressing cells (Figure 3c). Both cell lines, no matter they express 12 
low or high GFAP levels, are susceptible to SARS-CoV-2 infection. U-87 and U-373 also differ 13 
in glutamate uptake abilities, even though all glioma cell lines showed impaired glutamate 14 
uptake compared to normal human astrocytes (Ye and Sontheimer, 1999). While U-87 cells 15 
have lost this ability (data not shown), U-373 MG cells internalized glutamate upon addition of 16 
200 µM of glutamate in the medium (111.43.452 µM compared to 224.78.722 µM in basal 17 
medium without cells, p<0.001) (Figure 3d). Infection with various MOIs of SARS-CoV-2 18 
during 24 hours did not impact U-373 cells in their glutamate uptake abilities (one-way 19 
ANOVA, p= 0.4668 mock vs. MOI 0.1; p=0.0955 mock vs. MOI 1.0; p=0.9664 mock vs. MOI 20 
5.0). Finally, SARS-CoV-2 cytopathic effect on glioblastoma cells was evaluated by counting 21 
the number of cleaved caspase-3 positive cells at 24 hours of infection (Figure 3e). Infected U-22 
87 or U-373 did not show more apoptosis at any MOI tested than mock condition. For instance, 23 
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in U-87 and U-373 (p=n.s., compared to 2.830.83 % in mock conditions). Overall, 1 
glioblastoma cell lines were much less prone to apoptotic cell death than VeroE6 cells at 2 
comparable MOIs (two-way ANOVA, VeroE6 vs. U-87 MG: F(1,16)=38.70, p<0.001; VeroE6 3 
vs. U-373 MG : F(1,16)=38.78, p<0.001).  4 
 5 
 6 


































































Bielarz et al.  SARS-CoV-2 infection of neural cell lines 
11 
 
3. Discussion 1 
Our main findings are that SARS-CoV-2 is able to invade neuroblastoma and glioblastoma cell 2 
lines, without exerting major cytopathic effect on either neuron-like morphology or on 3 
functional glutamate uptake, and without inducing obvious apoptosis. Although the viral entry-4 
dependency on common entry genes was not investigated, a basal expression of ace2, tmprss2, 5 
cathepsin B and cathepsin L transcripts was detected in all cell lines. Noteworthy, RA-6 
differentiated neuroblastoma cells upregulated the gene expression of surface receptors such as 7 
ace2 and tmprss2. The definitive entry mechanisms inside nervous cells are still debated and 8 
existence of alternative surface receptors that might be hijacked cannot be ruled out, as it is 9 
described for SARS‐CoV and some epithelial cells or immune cells e.g. CD147/BSG, 10 
CD26/DPP4 (Radzikowska et al., 2020).  11 
Our experimental design allows to conclude that neuroblastoma and glioblastoma cells are 12 
modestly susceptible to SARS-CoV-2 infection, based on the high MOI needed to infect cells. 13 
In comparison to recent studies, human brain organoids and neurospheres were respectively 14 
infected with MOIs of 10.0 and 0.1 (Bullen et al., 2020; Zhang et al., 2020). At early infection 15 
timings (24h), neuroblastoma and glioblastoma cells were not as permissive as VeroE6 16 
epithelial cells. So far, contradictory results are reported about the SARS-CoV-2 replication 17 
into human neurons. While one study showed that SARS-CoV-2 entered neurons from brain 18 
organoids but did not replicate (Ramani et al., 2020), in two studies genomic viral material was 19 
found in the supernatant at higher level several hours post-infection than at the time zero of 20 
infection, which supports the release of new viral particles (Bullen et al., 2020; Zhang et al., 21 
2020). Intriguingly, we did not observe major SARS-CoV-2 cytopathic effect on any cell lines, 22 
unlike what was described in infected brain neurospheres or despite the evidences of neuronal 23 
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might be explained by a better resistance of tumor cell lines towards SARS-CoV-2 infection or 1 
a too short timing for apoptosis analysis. 2 
Bearing in mind the limitation that in situ hybridization – and not immunofluorescence nor 3 
electron microscopy - was used throughout this study to detect SARS-CoV-2, our confocal 4 
images comforted the intracellular localization of viral RNA. Interestingly, viral RNA was 5 
distributed in both soma, and neuron-like or glial-like extensions. So far, we did not investigate 6 
whether this distribution was due to random internalization along the cell membrane or whether 7 
internalized viral particles were able to be transported inside/along the cell processes. This last 8 
concept is relevant for deciphering the CNS entry routes. Among the entry pathways, the 9 
retrograde transport along nerve fibers from peripheral infected tissues (i.e. nasal cavity) or the 10 
hematogenous pathway across the blood-brain barrier (BBB) are being demonstrated 11 
(Meinhardt et al., 2020; Uversky et al., 2020). From our images showing SARS-CoV-2 RNA 12 
in the cell processes, it is tempting to hypothesize that neuron-like or glial-like cells might 13 
internalize viral particles at their farthest cell extension and then, using intracellular trafficking, 14 
carry them back to the soma. Corollary, SARS-CoV-2 might penetrate the CNS gate by first 15 
invading brain endothelial cells or following BBB disruption, then being caught at the 16 
perivascular astrocytic processes (Uversky et al., 2020). This hypothesis is supported by 17 
ultrastructural findings from autopsied COVID-19 patients, where authors captured viral 18 
particles at the endothelial-astrocyte interface (Bulfamante et al., 2020; Paniz-Mondolfi et al., 19 
2020). This passage would even be eased in the context of an important systemic inflammation 20 
that includes cytokines known to compromise BBB integrity (Uversky et al., 2020). 21 
This study on SARS-CoV-2 cell tropism is complementary to those using human pluripotent 22 
stem cell-based platform (Yang et al., 2020). Infection of neuroblastoma or glioblastoma cells 23 
might serve as an easy and low-cost model for testing drugs that interfere with viral entry, e.g. 24 
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4. Experimental Procedure 1 
4.1. Cell culture 2 
The SH-SY5Y neuroblastoma cell line, U-87 MG and U-373 MG glioblastoma cell lines were 3 
kindly provided by Profs. Jean-Pierre Brion and Karelle Leroy (Université Libre de Bruxelles, 4 
BE). The SK-N-BE(2) neuroblastoma cell line was a kind gift from Prof. Marielle Boonen 5 
(Université de Namur, BE). All cell lines were used between passage 15 and 25. They were 6 
maintained in DMEM/F12 (Life Technologies, Grand Island, NY, USA) supplemented with 10 7 
% fetal bovine serum (Sigma-Aldrich, Overijse, BE) and penicillin/streptomycin (Sigma-8 
Aldrich, Overijse, BE / Millipore, USA). Cells were grown in a sterile incubator at 37 °C, 95 9 
% air humidity and 5 % CO2 concentration. Culture medium was changed twice a week, 10 
depending on cell density, and cells were passaged for further cultivation or differentiation 11 
experiment at 80 – 90 % confluency. For passaging, cells were trypsinized using 0.05 % 12 
Trypsin/EDTA during 2 minutes, washed in medium and spun down at 130 g for 7 minutes and 13 
further split at a ratio 1:10. For differentiation experiment, SH-SY5Y and SK-N-BE(2) cells 14 
were seeded at a density of 20,000 cells per cm2, on glass coverslips pre-coated with 0.1 mg/ml 15 
Poly-L-lysine (Sigma-Aldrich, Overijse, BE). A differentiation protocol was applied based on 16 
7 day-exposure to 10 µM all-trans-retinoic acid (RA) (Sigma-Aldrich, Overijse, BE) added in 17 
low-serum medium (DMEM/F12 + 2% FBS + penicillin/streptomycin). RA-driven 18 
differentiation was initiated 24 h after seeding and fresh medium was replaced everyday up to 19 
day 7. Vero cells, clone E6 (VeroE6), were used to amplify a purified SARS-CoV-2 strain 20 
isolated from a Belgian COVID-19 patient.  21 
4.2. Infection with SARS-CoV-2 22 
All infections or viral amplification were performed in a biosafety level-3 laboratory 23 
(Université de Namur, BE). The SARS-CoV-2 isolate was kindly provided by Prof. Piet Maes 24 
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supernatant from infected Vero E6 cells. Neuroblastoma or glioblastoma cells were plated at a 1 
density of 20,000 cells per cm2 in a 24-well plate for in situ hybridization or a 12-well plate for 2 
gene expression studies. Cells were infected during 2- or 24- hours using a multiplicity-of-3 
infection (MOI) of 0.1, 1.0 or 5.0 in low-serum medium. For mock condition, cells were 4 
incubated with the low-serum medium-only. At the end of infection, culture medium was 5 
carefully discarded. Cells were thoroughly washed three times with PBS and either lyzed in 6 
TriZol or chemically-fixed with 4% paraformaldehyde, ensuring virus inactivation.    7 
4.3. RNA isolation and qRT-PCR 8 
Cells were homogenized in 1 mL of Trizol reagent and total RNA was further isolated according 9 
to manufacturer’s instructions (Life Technologies, Bleiswijk, NL). RNA concentrations were 10 
measured using a spetrophotometer Nanodrop 1000 (Thermo Scientific, Bleiswijk, NL). Total 11 
RNAs (1µg), including viral and human RNAs, were reverse-transcribed using the Super Script 12 
II RNase H reverse transcriptase kit according to manufacturer’s instructions (Invitrogen, 13 
Merelbeke, BE). cDNA was used to amplify SARS-CoV-2 gene E with Takyon Taqman kit 14 
and human genes with Takyon SYBR Green kit (Eurogentec, Liège, BE) in a Light Cycler 96 15 
device (Roche Diagnostics, Mannheim, DE) (Coupeau et al., 2020). Primer sequences are listed 16 
in Table 1. Relative gene expression was computed using the Cq method with hprt as 17 
housekeeping gene. 18 
4.4. in situ hybridization and immunofluorescence 19 
Coverslips were fixed in cold 4% paraformaldehyde during 20 minutes and then washed and 20 
stored in PBS at 4°C. Fixed cells were used within one-week post-fixation. Expression of 21 
SARS-CoV-2 gene S was detected according to manufacturer’s kit instructions (RNAScope, 22 
Advanced Cell Diagnostics, Bio-techne, Abingdon, UK) and by using a specific target probe 23 
(RNAscope Probe-V-nCoV2019-S, #848561, Bio-techne, Abingdon, UK). Briefly, cells were 24 
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peroxidases were blocked with hydrogen peroxide for 10 min followed by 2 washes in PBS. 1 
Cells were then incubated with RNAScope® Protease III (Advanced Cell Diagnostics Inc, 2 
Hayward, USA) for 10 min. and subsequently washed in PBS. Samples were incubated with 3 
the probe specifically targeting SARS-CoV-2 gene S mRNA (RNAScope, #422511, Advanced 4 
Cell Diagnostics, Bio-techne, Abingdon, UK) for 2 hours at 40°C and then washed for 2min in 5 
RNAScope® wash buffer (Advanced Cell Diagnostics, Bio-techne, Abingdon, UK). 6 
Amplification rounds 1-6 alternated from 30 to 15 min at 40°C. Between each amplification 7 
round, samples were washed with RNAScope® wash buffer. Detection of probe signals was 8 
performed by incubating samples with alkaline phosphatase (solution of RNAScope® Fast B 9 
and A ratio 1:60) for 10 min. at room temperature. Samples were then washed in milliQ water. 10 
Following ish, samples were either counterstained with hematoxylin (Sigma-Aldrich, Overijse, 11 
BE), dried for 30 min. at 60°C and mounted using VectaMount® (Vector Laboratories, 12 
Burlingame, USA) or fluorescently stained according to the protocol below. 13 
For ish/immunofluorescence multiplexing, coverslips were further washed 5 min at RT in PBS. 14 
Non-specific binding was blocked in a PBS-BSA 1% for 30min at RT. Then, samples were 15 
incubated with primary antibodies in PBS-BSA 1 % buffer overnight at RT: α-tubulin (1:500, 16 
T-5168, Sigma-Aldrich); GFAP (1:1000, G-3893, Sigma-Aldrich); cleaved caspase-3 (1:1000, 17 
#9664, Cell Signaling). After that, samples were washed 3X5 min with PBS-BSA 1%. 18 
Fluorophore-coupled secondary antibodies alexa fluor® 488 goat anti-mouse IgG 1:200 19 
(#A11001, Life Technologies, Oregon, USA) or goat anti-rabbit IgG 1:200 (#A11008, Life 20 
Technologies, Oregon, USA) in PBS-BSA1% were applied on their respective tissue sections 21 
and incubated for 30 min at RT. Afterwards, they were washed 3X5 min with PBS-BSA 1% 22 
and cell nuclei were stained in a solution of Hoechst 33258 (Life Technologies, Oregon, USA). 23 
Finally, after 1X5 min wash with PBS-BSA 1% and 2X5 min with PBS, tissue sections were 24 
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BX63 epifluorescence microscope equipped with SC50 camera for brightfield and XM10 1 
camera for fluorescence.  2 
4.5. Image analysis 3 
Intracellular virus distribution was analyzed using a Leica TCS SP5 confocal microscope. 4 
Individual cells among those that were in focal field were randomly chosen and the spatial 5 
relationship between SARS-CoV-2 ish probe signal and cytoskeleton network (-tubulin) was 6 
visually assessed. For each condition, 20 infected cells were at least acquired. All of the images 7 
were recorded at the same laser and multiplier settings.  8 
For neurite length assessment, multiple representative brightfields of SH-SY5Y cells were 9 
imaged using an inverted microscope Olympus CKX41 equipped with EP50 camera. The 10 
channels were extracted to grey scale and the length of 5 to 10 neurites per field was traced and 11 
measured, thereafter, from the distal end of neuron growth-cone, using the neurite tracer plugin 12 
NeuronJ (ImageJ add-on software), according to published protocol (Pemberton et al., 2018). 13 
From the images, at least 35 neurites per condition were quantified.  14 
For the analysis of caspase-3 immunolabeling, 100 cells per experimental condition were 15 
randomly acquired based on Hoescht nuclei counterstaining. The number of immunoreactive 16 
cleaved caspase-3+ cells was manually and blinded counted, and further related to 100 cell 17 
nuclei.  18 
4.6. Glutamate Uptake Assay 19 
The assay was adapted from Mahmoud et al. (Mahmoud et al., 2019). Briefly, 100,000 cells 20 
were seeded in each well of a 96-well plate, and washed 2 times with Hank’s Balanced Salt 21 
Solution (HBSS) containing Ca2+ and Mg2+: 1.26 mM CaCl2, 5.36 mM KCl, 0.44 mM 22 
KH2PO4, 0.811 mM MgSO4, 137 mM NaCl, 0.336 mM Na2HPO4, 4.166 mM NaHCO3, and 23 
5.55 mM d-glucose. Cells were then incubated with HBSS containing 200 µM L-glutamic acid 24 
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glutamate concentration in the medium was measured using a glutamate colorimetric assay kit 1 
according to the manufacturer’s instructions (#MAK004, Sigma-Aldrich, Overijse, BE). Total 2 
extracellular glutamate reflects the sum of glutamate uptake and release activities.  3 
4.7. Statistics 4 
Unless specified, all results were expressed as mean values ± Standard Error of Mean (SEM). 5 
Mann–Whitney was used to assess statistical significance between two groups. For multiple 6 
comparisons (≥3 groups), one-way non-parametric ANOVA test followed by Kruskal-Wallis 7 
post-hoc analysis was used to compare each MOI condition. When groups had to be compared 8 
based on two parameters (e.g. cell type and MOI), two-way non-parametric ANOVA test 9 
followed by Dunnett’s post-hoc analysis was used. The level of significance was set at p<0.05. 10 
The statistical analyses were performed using the software GraphPad Prism version 7 11 
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Table 1. Primer and probe sequences for qRT-PCR. 14 
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Figure captions (ALL FIGURES IN COLOR) 1 
Figure 1. Relative quantification of SARS-CoV-2 entry genes in human neural cell lines: ace2 2 
and tmprss2 (a); ctsb and ctsl (b). Ct cycles for entry genes were normalized to Ct cycles of 3 
human hprt and relative expression data were expressed as 2e-Ct. Statistical significance was 4 
assessed using Mann-Whitney only on SH-SY5Y and SK-N-BE(2) cells with or without  RA-5 
based differentiation. *p<0.05. Each box plots the median and extends from the 25th to 75th 6 
percentiles. Whiskers shows the min. and max. values. n=4 independent samples per condition. 7 
 8 
Figure 2. Chromogenic or fluorescent in situ hybridization (ish) using SARS-CoV-2 gene S 9 
probe (nCoV2019-S, red) were applied on RA-differentiated SH-SY5Y and SK-N-BE(2) cells 10 
exposed to SARS-CoV-2 at MOI 5.0 during 24 hours or to mock condition (a). Nuclei were 11 
counterstained with Hoechst (blue). Scale bar represents 50 µm. Viral RNA was detected in the 12 
cell body compartment of infected cells (black arrow) as well as along the neuritic processes 13 
(black arrowheads). Scale bar represents 10 µm. In comparison, infection of epithelial VeroE6 14 
cells with a lower MOI (0.1) of SARS-CoV-2 produced a massive ish signal in the cytoplasmic 15 
compartment (upper right panel). Scale bar represents 20 µm. Quantification of SARS-CoV-2 16 
gene E relative abundance in infected SH-SY5Y and SK-N-BE(2) according to various MOIs 17 
and timings of infection (b). Ct cycles for gene E were normalized to Ct cycles of human hprt 18 
and relative expression data were expressed as 2e-Ct. Statistical significance was calculated 19 
using a two-way ANOVA comparing each MOI and each timing. *p<0.05; ***p<0.001 for 20 
comparisons between each MOI, 
###
p<0.001 for comparisons between 2 hours and 24 hours of 21 
infection.  n=3 independent samples for each condition. Representative multiplex nCoV2019S 22 
ish (red)/ -tubulin (green) immunofluorescence images showed that viral RNA was in the 23 
same confocal plane as the cytoskeleton network in both infected neuroblastoma cell lines, 24 
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Orthogonal views from z-stack reconstruction confirmed the intracellular localization of SARS-1 
CoV-2 RNA signal. At 24 hours of infection, SARS-CoV-2 cytopathic effect was assessed by 2 
measuring the length of neuritic processes grown by RA-differentiated SH-SY5Y cells (d). 3 
Statistical significance was calculated using a one-way ANOVA comparing each MOI to mock 4 
condition. N=35-39 neurites counted per condition. At 24 hours of infection, SARS-CoV-2 5 
cytopathic effect was assessed by counting the number of cleaved caspase-3 immunoreactive 6 
SH-SY5Y or SK-N-BE(2) cells, and compared to MOI-matched VeroE6 cells (e). Statistical 7 
significance was calculated using a two-way ANOVA comparing each MOI and each cell type. 8 




p<0.001 for comparisons between MOI. N=100 cell nuclei counted per condition. 10 
Abbreviations: MOI, multiplicity-of-infection; n.d., not detected; n.s., not significant. 11 
 12 
Figure 3. Chromogenic in situ hybridization (ish) using SARS-CoV-2 gene S probe 13 
(nCoV2019-S) was applied on U-87 MG and U-373 MG cells exposed to SARS-CoV-2 at MOI 14 
5.0 during 24 hours or to mock condition (a). Scale bar represents 20 µm. Viral RNA was 15 
detected in the cell body compartment of infected cells as well as in the glial-like processes 16 
(inset in the upper right panel). Quantification of SARS-CoV-2 gene E relative abundance in 17 
infected SH-SY5Y and SK-N-BE(2) according to various MOIs and timings of infection (b). 18 
Ct cycles for gene E were normalized to Ct cycles of human hprt and relative expression data 19 
were expressed as 2e-Ct. Statistical significance was calculated using a two-way ANOVA 20 
comparing each MOI and each timing. **p<0.01; ***p<0.001 for comparisons between each 21 
MOI, 
###
p<0.001 for comparisons between 2 hours and 24 hours of infection. N=3 independent 22 
samples for each condition. Representative multiplex nCoV2019S ish (red)/ GFAP (green) 23 




































































Bielarz et al.  SARS-CoV-2 infection of neural cell lines 
20 
 
expressing cells (U-87 MG) and GFAP
high
-expressing cells (U-373 MG), upon infection with 1 
MOI 5.0 during 24 hours (c). Scale bar represents 20 µm. At 24 hours of infection, SARS-CoV-2 
2 cytopathic effect was assessed by quantifying the ability of U-373 MG cells to take up 3 
extracellular glutamate added to the culture supernatant (200 µM) (d). Infected U-373 MG cells 4 
were able to pump up glutamate from supernatant as efficiently as non-infected cells (p=n.s.). 5 
Statistical significance was calculated using a one-way ANOVA comparing each MOI to mock 6 
condition. N=6 independent samples per condition. At 24 hours of infection, SARS-CoV-2 7 
cytopathic effect was assessed by counting the number of cleaved caspase-3 immunoreactive 8 
U-87 MG or U-373 MG cells, and compared to MOI-matched VeroE6 cells (e). Statistical 9 
significance was calculated using a two-way ANOVA comparing each MOI and each cell type. 10 




p<0.001 for comparisons between MOI. n=100 cell nuclei counted per condition. 12 
Abbreviations: MOI, multiplicity-of-infection; n.d., not detected; n.s., not significant. 13 
 14 
 15 
Suppl. Fig. 1. Representative confocal images of SARS-CoV-2 infected neuroblastoma cells, 16 
labeled for nCoV2019-S (red), -tubulin (green) and counterstained with Hoechst (blue nuclei). 17 
Analysis of peak fluorescence intensity from one confocal plane shows the co-localization of 18 
red and green peaks at several distances (asterix) along the region-of-interest. 19 
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